Open AccessMetadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis
Author(s) -
Fátima Higuera-de la Tijera,
A. Servín-Caamaño,
Aurora E. SerraldeZúñiga,
Javier Enrique Cruz-Herrera,
Eduardo Pérez-Torres,
Juan Miguel Abdo-Francis,
Francisco Salas-Gordillo,
J.L. Pérez-Hernández
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i16.4975
Subject(s) - medicine , abstinence , gastroenterology , alcoholic hepatitis , alcoholic liver disease , cirrhosis , psychiatry
To evaluate the impact of metadoxine (MTD) on the 3- and 6-mo survival of patients with severe alcoholic hepatitis (AH).